We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02625623
Brief Title: Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

First Submitted : December 4, 2015
First Submitted that Met QC Criteria : December 4, 2015
First Posted : December 9, 2015 (Estimate)

Last Update Submitted : January 16, 2018
Last Update Submitted that Met QC Criteria : January 16, 2018
Last Update Posted : January 18, 2018